We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test uncovers actionable disease-defining transcriptional biology. 

Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. 

By partnering with developers of new medicines and advancing our own diagnostic tests, we’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.

Health Data

Life Sciences

Medical Devices

Therapeutics

Precede Biosciences

Rehan Verjee

Matthew Eaton

Juliann Chmielecki

Corrie Painter

Kush Parmar

Jennifer Fortune

Geoff Otto

The Leadership Team at Precede Biosciences is responsible for setting the strategic direction and overseeing the execution of company initiatives. This team aligns key operational, research, and development activities, fosters strategic partnerships, and ensures the company's vision to advance diagnostic and therapeutic solutions is met. By leveraging their diverse expertise, they drive innovation and growth while ensuring that the company remains at the forefront of translational and computational biology.


Leadership Team

Product Development Team

Associate Directors

Leadership Team

About

Team members

Other teams at Precede Biosciences

Product Development Team

Associate Directors